Skip to content

Comparing Two Feeding Tube Methods to Improve Nutrition and Recovery after Stomach Cancer Surgery

Nutritional Impact of Prophylactic Feeding Jejunostomy in Major Upper GI Cancer Surgery: A Prospective Cohort Study of 300 Patients - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113935
Enrollment
300
Registered
2026-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Prophylactic Feeding Jejunostomy: Patients undergoing curative major upper gastrointestinal cancer surgery will receive prophylactic feeding jejunostomy placement during surgery Wiegh

Sponsors

Basavatarakam Indo American Cancer Hospital and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 75 years Histologically confirmed upper gastrointestinal malignancy Patients scheduled for curative-intent major upper GI oncologic surgery such as esophagectomy gastrectomy or pancreatoduodenectomy with planned prophylactic feeding jejunostomy placement ECOG performance status 0 to 2 Ability and willingness to provide written informed consent

Exclusion criteria

Exclusion criteria: Patients undergoing palliative surgery only Patients with pre-existing enteral feeding access eg PEG or jejunostomy Known allergy or hypersensitivity to jejunostomy tube materials Expected survival less than 3 months due to advanced disease or severe comorbidities Pregnant patients

Design outcomes

Primary

MeasureTime frame
Absolute change in body weight in kgs from preoperative baseline to 3 months after surgery in patients undergoing major upper gastrointestinal cancer surgery with prophylactic feeding jejunostomyTimepoint: at baseline and at 3 months

Secondary

MeasureTime frame
Mean change in serum albumin levels from baseline to 3 monthsTimepoint: At baseline At 2 weeks At 4 weeks & at 3 months postoperatively;Incidence & type of FJ related complications graded according to Clavien Dindo classificationTimepoint: Within 3 months after surgery

Countries

India

Contacts

Public ContactSyed Nusrath

Basavatarakam Indo American Cancer Hospital and Research Institute

dr.nusrath2008@gmail.com9030747486

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026